Table 5. WHO severity score of the pregnant COVID-19 women pre-tocilizumab and followed up on days 2, 5, 10, 30, and 60.
WHO severity scale | Admission | Pre-tocilizumab | Post-tocilizumab administration day | ||||
Day 2 | Day 5 | Day 10 | Day 30 | Day 60 | |||
1 | - | - | - | - | 1 | 24 | 25 |
2 | - | - | - | - | 11 | - | - |
3 | 1 | - | - | - | - | - | - |
4 | 3 | - | - | 8 | 5 | - | - |
5 | 24 | - | 1 | 8 | 3 | - | - |
6 | - | 28 | 27 | 12 | 8 | 1 | - |
7 | - | - | - | - | - | - | - |
8 | - | - | - | - | - | 2 | 1 |
9 | - | - | - | - | - | - | - |
10 | - | - | - | - | - | 1 | 2 |